MATTHEW W TOWSE Insider Trading $NXTM NxStage Medical, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for MATTHEW W TOWSE.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of MATTHEW W TOWSE. MATTHEW W TOWSE is Senior Vice President in FAIRCHILD SEMICONDUCTOR INTERNATIONAL INC ($FCS) and Senior Vice President, CFO in FAIRCHILD SEMICONDUCTOR INTERNATIONAL INC ($FCS) and Sr VP, CFO in FAIRCHILD SEMICONDUCTOR INTERNATIONAL INC ($FCS) and SVP and Chief Financial Office in NxStage Medical, Inc. ($NXTM).

MATTHEW W TOWSE in NxStage Medical, Inc.

Trading Symbol: NXTM
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of MATTHEW W TOWSE: SVP and Chief Financial Office
Holdings: 30,242 shares
Current Value: $840,123
Latest Transaction: Mar 12 2018
$NXTM Market Capitalization: $1.80B
$NXTM Previous Close: $27.78

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of MATTHEW W TOWSE in NxStage Medical, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, FCS, NXTM

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 12 2018NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseM0.005,821011,643
Mar 12 2018NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseA0.0017,464017,464
Mar 12 2018NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Payment of ExerciseF24.371,84644,98728,39630.2 K to 28.4 K (-6.10 %)
Mar 12 2018NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...BuyM0.005,821030,24224.4 K to 30.2 K (+23.84 %)
Oct 23 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseM14.054,03056,6220
Oct 23 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...SellS27.504,030110,82524,42128.5 K to 24.4 K (-14.16 %)
Oct 23 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...BuyM14.054,03056,62228,45124.4 K to 28.5 K (+16.50 %)
Sep 21 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseM14.054,30060,4154,030
Sep 21 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...SellS27.274,300117,26124,42128.7 K to 24.4 K (-14.97 %)
Sep 21 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...BuyM14.054,30060,41528,72124.4 K to 28.7 K (+17.61 %)
Aug 23 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseM14.054,30060,4158,330
Aug 23 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...SellS29.224,300125,64624,42128.7 K to 24.4 K (-14.97 %)
Aug 23 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...BuyM14.054,30060,41528,72124.4 K to 28.7 K (+17.61 %)
Jul 21 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseM14.054,30060,41512,630
Jul 21 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...SellS24.164,300103,88824,42128.7 K to 24.4 K (-14.97 %)
Jul 21 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...BuyM14.054,30060,41528,72124.4 K to 28.7 K (+17.61 %)
Jul 17 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Payment of ExerciseF24.2891622,24024,42125.3 K to 24.4 K (-3.62 %)
Jun 21 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseM14.054,30060,41516,930
Jun 21 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...SellS23.294,300100,14725,33729.6 K to 25.3 K (-14.51 %)
Jun 21 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...BuyM14.054,30060,41529,63725.3 K to 29.6 K (+16.97 %)
May 23 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseM14.054,30060,41521,230
May 23 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...SellS21.364,30091,84825,33729.6 K to 25.3 K (-14.51 %)
May 23 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...BuyM14.054,30060,41529,63725.3 K to 29.6 K (+16.97 %)
Apr 20 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseM14.054,30060,41525,530
Apr 20 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...SellS27.284,300117,30425,33729.6 K to 25.3 K (-14.51 %)
Apr 20 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...BuyM14.054,30060,41529,63725.3 K to 29.6 K (+16.97 %)
Mar 22 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseM14.054,30060,41529,830
Mar 22 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...SellS27.664,300118,93825,33729.6 K to 25.3 K (-14.51 %)
Mar 22 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...BuyM14.054,30060,41529,63725.3 K to 29.6 K (+16.97 %)
Mar 13 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseA27.8949,8551,390,45649,855
Mar 06 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseM0.009,74700
Mar 06 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Payment of ExerciseF28.313,15189,20525,33728.5 K to 25.3 K (-11.06 %)
Mar 06 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...BuyM0.009,747028,48818.7 K to 28.5 K (+52.01 %)
Feb 23 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseM14.054,30060,41534,130
Feb 23 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...SellS29.264,300125,81818,74123 K to 18.7 K (-18.66 %)
Feb 23 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...BuyM14.054,30060,41523,04118.7 K to 23 K (+22.94 %)
Jan 23 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseM14.054,30060,41538,430
Jan 23 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...SellS26.194,300112,61718,74123 K to 18.7 K (-18.66 %)
Jan 23 2017NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...BuyM14.054,30060,41523,04118.7 K to 23 K (+22.94 %)
Dec 20 2016NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseM14.054,30060,41542,730
Dec 20 2016NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...SellS25.554,300109,86518,74123 K to 18.7 K (-18.66 %)
Dec 20 2016NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...BuyM14.054,30060,41523,04118.7 K to 23 K (+22.94 %)
Nov 21 2016NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseM14.054,30060,41547,030
Nov 21 2016NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...SellS26.234,300112,78918,74123 K to 18.7 K (-18.66 %)
Nov 21 2016NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...BuyM14.054,30060,41523,04118.7 K to 23 K (+22.94 %)
Jul 18 2016NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Payment of ExerciseF21.7368814,95018,74119.4 K to 18.7 K (-3.54 %)
Mar 10 2016NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseA15.5889,3861,392,63489,386
Mar 07 2016NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseM0.009,74609,747
Mar 07 2016NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Payment of ExerciseF15.483,26450,52719,42922.7 K to 19.4 K (-14.38 %)
Mar 07 2016NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...BuyM0.009,746022,69312.9 K to 22.7 K (+75.28 %)
Jan 11 2016NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseM14.053,47248,78251,330
Jan 11 2016NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...SellS20.403,47270,82912,94716.4 K to 12.9 K (-21.15 %)
Jan 11 2016NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...BuyM14.053,47248,78216,41912.9 K to 16.4 K (+26.82 %)
Dec 17 2015NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseM14.052,86340,22554,802
Dec 17 2015NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...SellS19.512,86355,85712,94715.8 K to 12.9 K (-18.11 %)
Dec 17 2015NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...BuyM14.052,86340,22515,81012.9 K to 15.8 K (+22.11 %)
Nov 12 2015NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseM14.052,86340,22557,665
Nov 12 2015NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...SellS20.322,86358,17612,94715.8 K to 12.9 K (-18.11 %)
Nov 12 2015NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...BuyM14.052,86340,22515,81012.9 K to 15.8 K (+22.11 %)
Nov 04 2015NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseM14.058,591120,70460,528
Nov 04 2015NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...SellS19.508,591167,52512,94721.5 K to 12.9 K (-39.89 %)
Nov 04 2015NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...BuyM14.058,591120,70421,53812.9 K to 21.5 K (+66.36 %)
Aug 10 2015NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...SellS15.525,45584,66212,94718.4 K to 12.9 K (-29.64 %)
Jul 17 2015NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Payment of ExerciseF14.444596,62818,40218.9 K to 18.4 K (-2.43 %)
Mar 05 2015NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseM0.009,746019,493
Mar 05 2015NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseA0.0029,239029,239
Mar 05 2015NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Option ExerciseA16.6665,6181,093,19665,618
Mar 05 2015NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...Payment of ExerciseF16.663,16252,67918,86122 K to 18.9 K (-14.36 %)
Mar 05 2015NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...BuyM0.009,746022,02312.3 K to 22 K (+79.38 %)
Mar 05 2015NXTMNxStage Medical, I ...TOWSE MATTHEW WSVP and Chief Finan ...GrantA16.665,45590,88012,2776.8 K to 12.3 K (+79.96 %)

Page:   1